Vfend paediatric dose changed

It is no longer recommended to use a loading dose of the antifungal agent Vfend (voriconazole) when treating children aged 2 to 12 years.

For serious fungal infections in children aged 2 to 12 years the recommended dose is 200 mg (5 ml) Vfend suspension orally twice daily or 7 mg/kg Vfend infusion twice daily or 4mg/kg twice daily if the higher intravenous dose is not tolerated.

Pharmacokinetic data in children and adults indicate that in order to obtain comparable exposures of voriconazole to those in adults a dose of 200 mg of oral suspension twice daily is required in paediatric patients, independent of body weight.

The proportionately higher intravenous dose in children relative to adults reflects the higher elimination capacity in children due to a greater liver mass to body mass ratio.

View Vfend drug record

Further Information: Walton Oaks

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases